Effect of oral metrizamide on hematocrit and serum osmolality in the neonate

Investigative Radiology
|November 1, 1984
PubMed

Insights

Oral metrizamide is a safe and effective agent for evaluating gastrointestinal issues in newborns and infants. This study found good to excellent imaging results with no adverse effects on key health indicators.

Area of Science:

  • Pediatric Radiology
  • Gastroenterology
  • Medical Imaging

Background:

  • Gastrointestinal pathology in newborns requires accurate diagnostic methods.
  • Evaluating the safety and efficacy of contrast agents in infants is crucial.

Purpose of the Study:

  • To assess the safety and effectiveness of oral metrizamide for neonatal gastrointestinal examinations.
  • To determine the diagnostic quality of images obtained using metrizamide in infants.

Main Methods:

  • Sixteen newborns and young infants (800-5200g) received oral metrizamide.
  • Radiographic images were evaluated for diagnostic quality.
  • Hematocrit and serum osmolality were monitored for adverse effects.

Main Results:

  • Oral metrizamide was administered to 16 infants for suspected gastrointestinal pathology.
  • 14 out of 16 cases (87.5%) yielded good to excellent image quality.
  • No significant changes in hematocrit or serum osmolality were observed post-administration.

Conclusions:

  • Metrizamide is a safe and effective oral contrast agent for neonatal gastrointestinal imaging.
  • The agent provides high-quality images, aiding in the diagnosis of infant gastrointestinal conditions.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...